A role for chondroitin sulphate B in the activity of interleukin 12 in stimulating γ-interferon secretion

Immunology Letters

Volumn 85, Issue 1, 2003, Pages 53-58

  Garnier, Pascale ^a   Gibbs, Roslyn V ^b   Rider, Christopher C ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Chondroitin sulfate; Interleukin 12; Natural killer cells; Th1 response

Indexed keywords

CHONDROITIN ABC LYASE; DERMATAN SULFATE; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; INTERLEUKIN 12; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INTERFERON PRODUCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEOGLYCAN SYNTHESIS; QUANTITATIVE ANALYSIS;

ANIMALS; CELL DIFFERENTIATION; DERMATAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; MICE;

EID: 0037413476     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(02)00211-0     Document Type: Article

References (24)

1. Kolset S.O., Gallagher J.T. Proteoglycans in haemopoietic cells. Biochim. Biophys. Acta. 1032:1990;191-211.
2. Hoogewerf A.J., Kuschert G.S.V., Proudfoot A.E.I., Bortlat F., Clark-Lewis I., Power C.A., Wells T.N.C. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 36:1997;13570-13578.
3. Mummery R.S., Rider C.C. Characterization of the heparin-binding properties of IL-6. J. Immunol. 165:2000;5671-5679.
4. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 91:1997;385-395.
5. Webb L.M.C., Ehrengruber M.U., Clark-Lewis I., Baggiolini M., Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA. 90:1993;7158-7162.
6. Lortat-Jacob H., Baltzer F., Grimaud J.-A. Heparin decreases the blood clearance of interferon-γ and increases its activity by limiting the processing of its carboxyl-terminal sequence. J. Biol. Chem. 271:1996;16139-16143.
7. Rapraeger A.C., Krufka A., Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1991;1705-1708.
8. Yayon A., Klagsburn M., Esko J.D., Leder P., Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
9. Plotnikov A.N., Schlessinger J., Hubbard S.R., Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell. 98:1999;641-650.
10. Pellegrinin L., Burke D.F., von Delft F., Mulloy B., Blundell T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:2000;1029-1034.
11. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., Presky D.H. The interleukin-12/interleukin-12-receptor system: role in normal and pathological immune responses. Ann. Rev. Immunol. 16:1998;495-521.
12. Hasan M., Najjam S., Gordon M.Y., Gibbs R.V., Rider C.C. IL-12 is a heparin-binding cytokine. J. Immunol. 162:1999;1064-1070.
13. Karlhofer F.M., Orihuela M.M., Yokoyama W.M. Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice. J. Exp. Med. 181:1995;1785-1795.
14. Hurt-Camejo E., Rosengren B., Sartipy P., Elfsberg K., Camejo G., Svensson L. CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-γ and some of its biological effects on human vascular smooth muscle cells. J. Biol. Chem. 274:1999;18957-18964.
15. Schwartz N.B., Galligani L., Ho P.-L., Dorfman A. Stimulation of the synthesis of free chondroitin sulfate chains by β-D-xylosides. Proc. Natl. Acad. Sci. USA. 71:1974;4047-4051.
16. Christmas S.E., Steward W.P., Lyon M., Gallagher J.T., Moore M. Chondroitin sulphate proteoglycan production by NK cells and T cells: effects of xylosides on proliferation and cytotoxic function. Immunology. 63:1988;225-231.
17. Schmidt R.E., MacDermott R.P., Bartley G., Bertovich M., Amato D.A., Austen K.F., Schlossman S.F., Stevens R.L., Ritz J. Specific release of proteoglycans from human natural killer cells during target lysis. Nature. 318:1985;289-291.
18. Avraham S., Stevens R.L., Nicodemus C.F., Gartner M.C., Austen K.F., Weis J.H. Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogue rat and human cDNA. Proc. Natl. Acad. Sci. USA. 86:1989;3763-3767.
19. MacDermott R.P., Schmidt R.E., Caulfield J.P., Hein A., Bartley G.T., Ritz J., Schlossman S.F., Austen K.F., Stevens R.L. Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulphate proteoglycan from human cloned natural killer cells during target cell lysis. J. Exp. Med. 162:1985;1771-1787.
20. Bland C.E., Rosnethal K.L., Puznik D.L., Dennert G., Hengartner H., Bienestock J., Metcalfe D.D. Glycosaminoglycan profiles in cloned granulated lymphocytes with natural killer function and in cultured mast cells: their potential use as biochemical markers. J. Immunol. 132:1984;1937-1942.
21. Valles S., Tsoi C., Huang W.-Y., Wyllie D., Carlotti F., Askari J.A., Humphries M.J., Dower S.K., Qwarnström E.E. Recruitment of a heparan sulfate subunit to the interleukin-1 receptor complex. J. Biol. Chem. 271:1999;20103-20109.
22. Najjam S., Gibbs R.V., Gordon M.Y., Rider C.C. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine. 9:1997;1013-1022.
23. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitin ABCase. Nat. Neurosci. 4:2001;465-466.
24. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal injury. Nature. 416:2002;636-640.